Cerena Chen
Stock Analyst at Wells Fargo
(2.79)
# 1,811
Out of 5,124 analysts
5
Total ratings
100%
Success rate
35.44%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $160.17 | -66.29% | 1 | Sep 30, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $27.71 | +26.31% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $172.44 | -4.31% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $160.17
Upside: -66.29%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $27.71
Upside: +26.31%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $172.44
Upside: -4.31%